Investigation of the Effects of Quadratus Lumborum Block Applied to Patients in Kidney Transplant Surgery
Comparison of the Effects of Quadratus Lumborum Block (QLB) Applied for Preemptive Analgesia on Post-operative Pain in Recipients and Donors in Renal Transplantation Surgery With Intravenous Analgesic (IVA) Group
1 other identifier
observational
94
1 country
1
Brief Summary
This study aims to determine the most effective and long-lasting pain relief method for post-operative analgesia in kidney donor and recipient patients in kidney transplantation programme with the least invasive and least drug administration. For this reason, it is planned to perform Quadratus lumborum plane block (QLB) in a group of patients who will be kidney donors and kidney recipients in kidney transplantation and who meet the American Society of Anesthesiologists (ASA) Physical Status Classification System 1-3 risk classification between the ages of 18-70 years, and to administer intravenous pain medication without block in another group. It is planned to include at least 84 patients in the Quadratus lumborum plan block (QLB) and Intravenous Analgesia group (IVA) without gender discrimination. Postoperative Sedation-Agitation assessment and NRS (numeric pain scale) at 1st hour, 2nd, 6th, 12th and 24th hours, as well as possible side effects such as nausea, vomiting, shoulder pain, respiratory depression, bradycardia and hypotension, total amount of opioid analgesics consumed within 24 hours and duration of hospital stay will be observed and recorded.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 8, 2023
CompletedFirst Posted
Study publicly available on registry
August 25, 2023
CompletedStudy Start
First participant enrolled
October 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 6, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 7, 2024
CompletedFebruary 26, 2025
February 1, 2025
7 months
August 8, 2023
February 24, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Assessment of pain (NRS) level
The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable"
postoperative 1st, 2nd, 6th, 12th, 24th hours
Secondary Outcomes (9)
Sedation- agitation level
Will be assessed from immediately after extubation until transfer from the recovery room to the ward.
Duration of first analgesic requirement
During the 24 hours postoperative period
Blood pressure measurement
It will be recorded 10 minutes before induction of anesthesia and every 15 minutes after intubation until the end of the operation.
Measurement of heart rate
It will be recorded 10 minutes before induction of anesthesia and every 15 minutes after intubation until the end of the operation.
Amount of fentanyl consumed during the operation
During surgery
- +4 more secondary outcomes
Study Arms (4)
Kidney Donor QLB Group
Quadratus lumborum block (QLB) will be applied to the kidney donor in kidney transplant surgery immediately after induction of general anesthesia before the surgical incision is started.
Kidney Donor Paracetamol Group
In kidney transplantation surgery, 1000 milligrams of Paracetamol will be administered intravenously to the kidney donor before the surgical incision is started, immediately after induction of general anesthesia.
Kidney Recipient QLB Group
Quadratus lumborum block (QLB) will be applied to the kidney recipient in kidney transplant surgery immediately after induction of general anesthesia before the surgical incision is started.
Kidney Recipient Paracetamol Group
In kidney transplantation surgery, 1000 milligrams of Paracetamol will be administered intravenously to the kidney recipient before the surgical incision is started, immediately after induction of general anesthesia.
Eligibility Criteria
Being a kidney recipient and donor in an organ transplant program
You may qualify if:
- Patients aged 18-70 years,
- American Society of Anesthesiologists (ASA) Physical Status Classification System I-III,
- Being a volunteer kidney recipient or volunteer donor in a kidney transplant programme under general anaesthesia
You may not qualify if:
- Age \<18 years or \> 70 years
- American Society of Anesthesiologists (ASA) Physical Status Classification System \>III
- body mass index (BMI) \> 35 kg/m2
- known allergy to local anaesthetics or paracetamol/tramadol
- presence of preoperative chronic pain
- presence of accumulated fluid or cystic formation in the abdomen
- presence of coagulopathy
- those who are unable to give written consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Diyarbakır, 21070, Turkey (Türkiye)
Related Publications (1)
Sindwani G, Sahu S, Suri A, Sureka S, Thomas M. Efficacy of ultrasound guided quadratus lumborum block as postoperative analgesia in renal transplantation recipients: A randomised double blind clinical study. Indian J Anaesth. 2020 Jul;64(7):605-610. doi: 10.4103/ija.IJA_21_20. Epub 2020 Jul 1.
PMID: 32792737BACKGROUND
Study Officials
- STUDY CHAIR
Fatma Acil, M.D.
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 8, 2023
First Posted
August 25, 2023
Study Start
October 3, 2023
Primary Completion
May 6, 2024
Study Completion
May 7, 2024
Last Updated
February 26, 2025
Record last verified: 2025-02